Dong-A ST 将来の成長

Future 基準チェック /36

Dong-A ST利益と収益がそれぞれ年間65.5%と6.2%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に6.8% 65.8%なると予測されています。

主要情報

65.5%

収益成長率

65.8%

EPS成長率

Pharmaceuticals 収益成長	37.3%
収益成長率	6.2%
将来の株主資本利益率	6.8%
アナリストカバレッジ	Good
最終更新日	04 Nov 2024

今後の成長に関する最新情報

Recent updates

Is Dong-A ST (KRX:170900) A Risky Investment?

Oct 16

Investor Optimism Abounds Dong-A ST Co., Ltd. (KRX:170900) But Growth Is Lacking

Aug 21

Dong-A ST's (KRX:170900) Shareholders Have More To Worry About Than Only Soft Earnings

Mar 25

Dong-A ST Co., Ltd. (KRX:170900) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Mar 07

Is Dong-A ST Co., Ltd.'s (KRX:170900) Stock's Recent Performance A Reflection Of Its Financial Health?

Feb 09

Is Dong-A ST Co., Ltd. (KRX:170900) Popular Amongst Institutions?

Jan 25

Is Dong-A ST Co., Ltd. (KRX:170900) A Good Fit For Your Dividend Portfolio?

Jan 11

Be Sure To Check Out Dong-A ST Co., Ltd. (KRX:170900) Before It Goes Ex-Dividend

Dec 25

Dong-A ST (KRX:170900) Has A Rock Solid Balance Sheet

Dec 22

Calculating The Intrinsic Value Of Dong-A ST Co., Ltd. (KRX:170900)

Dec 07

A Look At Dong-A ST's (KRX:170900) Share Price Returns

Nov 19

業績と収益の成長予測

KOSE:A170900 - アナリストの将来予測と過去の財務データ ( )KRW Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	775,160	55,667	75,000	67,350	5
12/31/2025	730,917	43,033	56,667	51,975	6
12/31/2024	666,717	29,733	27,000	47,750	6
6/30/2024	675,406	-6,678	-62,022	-26,165	N/A
3/31/2024	672,231	-5,182	-50,385	-9,557	N/A
12/31/2023	663,980	11,122	-38,489	3,374	N/A
9/30/2023	637,080	5,289	-56,043	-9,441	N/A
6/30/2023	632,152	18,314	-32,755	15,843	N/A
3/31/2023	626,247	19,507	-56,251	3,549	N/A
12/31/2022	635,393	13,552	-33,653	32,895	N/A
9/30/2022	634,156	20,490	-32,798	51,531	N/A
6/30/2022	624,348	10,545	-41,970	46,424	N/A
3/31/2022	608,566	13,792	-24,770	61,727	N/A
12/31/2021	593,228	12,816	-31,066	49,374	N/A
9/30/2021	568,502	4,029	-28,714	37,764	N/A
6/30/2021	562,255	-3,362	-32,402	29,698	N/A
3/31/2021	526,362	-18,566	-32,629	16,974	N/A
12/31/2020	586,728	27,103	-14,916	27,031	N/A
9/30/2020	614,778	64,631	14,983	46,006	N/A
6/30/2020	630,909	80,237	45,142	64,313	N/A
3/31/2020	670,903	97,181	47,835	64,399	N/A
12/31/2019	612,311	70,913	37,509	56,254	N/A
9/30/2019	594,546	21,310	46,231	64,385	N/A
6/30/2019	573,442	7,015	22,026	37,878	N/A
3/31/2019	574,391	20,620	41,189	55,250	N/A
12/31/2018	567,434	8,009	41,457	50,136	N/A
9/30/2018	574,260	24,985	39,569	47,442	N/A
6/30/2018	577,496	30,598	33,200	42,154	N/A
3/31/2018	557,657	13,574	N/A	28,967	N/A
12/31/2017	555,027	-5,396	N/A	51,233	N/A
9/30/2017	534,096	13,724	N/A	40,602	N/A
6/30/2017	526,621	-4,703	N/A	47,631	N/A
3/31/2017	546,731	-13,140	N/A	13,167	N/A
12/31/2016	560,535	2,623	N/A	1,890	N/A
9/30/2016	576,257	9,384	N/A	2,383	N/A
6/30/2016	588,973	27,434	N/A	5,928	N/A
3/31/2016	572,577	43,069	N/A	49,091	N/A
12/31/2015	567,940	47,495	N/A	42,397	N/A
9/30/2015	573,434	42,755	N/A	54,475	N/A
6/30/2015	560,372	42,855	N/A	70,798	N/A
3/31/2015	574,235	37,791	N/A	72,214	N/A
12/31/2014	578,640	37,412	N/A	84,746	N/A
9/30/2014	685,763	24,320	N/A	72,487	N/A
6/30/2014	703,607	20,485	N/A	64,126	N/A
12/31/2013	601,161	-78,858	N/A	-17,063	N/A

アナリストによる今後の成長予測

収入対貯蓄率: A170900は今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.7% ) よりも高い成長率であると考えられます。

収益対市場: A170900今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: A170900今後 3 年以内に収益を上げることが予想されます。

収益対市場: A170900の収益 ( 6.2% ) KR市場 ( 9.7% ) よりも低い成長が予測されています。

高い収益成長: A170900の収益 ( 6.2% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: A170900の自己資本利益率は、3年後には低くなると予測されています ( 6.8 %)。

Dong-A ST 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Price target increased by 8.5% to ₩84,247

Price target increased by 7.6% to ₩77,624

Price target decreased to ₩77,200

Price target decreased to ₩95,667

Price target decreased to ₩105,000

Recent updates

Dong-A ST Co., Ltd. to Report Q3, 2024 Results on Nov 01, 2024

Is Dong-A ST (KRX:170900) A Risky Investment?

US FDA Approves Dong-A ST's Imuldosa (ustekinumab-Sslf), a Biosimilar to Stelara

New minor risk - Shareholder dilution

Investor Optimism Abounds Dong-A ST Co., Ltd. (KRX:170900) But Growth Is Lacking

Dong-A ST Co., Ltd. to Report First Half, 2024 Results on Jul 25, 2024

Price target increased by 8.5% to ₩84,247

Less than half of directors are independent

Dong-A ST Co., Ltd. to Report Q1, 2024 Results on May 02, 2024

Dong-A ST's (KRX:170900) Shareholders Have More To Worry About Than Only Soft Earnings

Full year 2023 earnings released: EPS: ₩1,311 (vs ₩1,606 in FY 2022)

Dong-A ST Co., Ltd. (KRX:170900) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

Price target increased by 7.6% to ₩77,624

Now 22% overvalued after recent price rise

Dong-A ST Co., Ltd. to Report Fiscal Year 2023 Results on Feb 15, 2024

FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara

Upcoming dividend of ₩686 per share at 1.1% yield

New minor risk - Profit margin trend

Investor sentiment improves as stock rises 21%

New minor risk - Share price stability

Investor sentiment improves as stock rises 28%

Dong-A ST Co., Ltd. to Report Q2, 2023 Results on Jul 27, 2023

Now 21% undervalued after recent price drop

EMA Accepts MAA for DMB-3115 of Dong-A ST, a Stelara Biosimilar

Full year 2022 earnings released: EPS: ₩1,606 (vs ₩1,519 in FY 2021)

Dong-A ST Co., Ltd. Demonstrates Therapeutic Equivalence Between DMB-3115 and Stelara in Global Phase III

Upcoming dividend of ₩1,000 per share

High number of new directors

Price target decreased to ₩77,200

Price target decreased to ₩95,667

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of ₩1,000 per share

Price target decreased to ₩105,000

Does Dong-A ST (KRX:170900) Have A Healthy Balance Sheet?

Dong-A ST's (KRX:170900) Problems Go Beyond Weak Profit

Full year 2020 earnings released: EPS ₩3,212 (vs ₩8,404 in FY 2019)

A Look At The Fair Value Of Dong-A ST Co., Ltd. (KRX:170900)

Dong-A ST Co., Ltd., Annual General Meeting, Mar 24, 2021

New 90-day low: ₩82,100

A Look At Dong-A ST's (KRX:170900) Share Price Returns

Is Dong-A ST Co., Ltd.'s (KRX:170900) Stock's Recent Performance A Reflection Of Its Financial Health?

Dong-A ST Co., Ltd. Completes the Proof-Of-Concept Study for ‘DA-1241,’ an Investigational First-In-Class Small Molecule with Mechanism of GPR119 Agonist Under Clinical Development, in Patients with Type 2 Diabetes

Dong-A ST Co., Ltd. to Report Fiscal Year 2020 Results on Feb 03, 2021

New 90-day low: ₩82,500

Is Dong-A ST Co., Ltd. (KRX:170900) Popular Amongst Institutions?

Is Dong-A ST Co., Ltd. (KRX:170900) A Good Fit For Your Dividend Portfolio?

Be Sure To Check Out Dong-A ST Co., Ltd. (KRX:170900) Before It Goes Ex-Dividend

Dong-A ST (KRX:170900) Has A Rock Solid Balance Sheet

Upcoming Dividend of ₩1,000 Per Share

New 90-day low: ₩83,800

Calculating The Intrinsic Value Of Dong-A ST Co., Ltd. (KRX:170900)

A Look At Dong-A ST's (KRX:170900) Share Price Returns

New 90-day low: ₩85,000

New 90-day high - ₩104,500

Dong-A ST Co., Ltd. to Report First Half, 2020 Results on Jul 29, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘